Projects per year
Personal profile
Biography
I am Pharmacologist interested in analgesics and other psychoactive drugs, particularly cannabinoids and opioids. My lab studies how opioids, cannabinoids and related molecules interact with G protein coupled receptors and ion channels to exert their effects. Currently my work is focussed on how clinically used opioids interact with naturally occuring variants of human opioid receptors, the pharmacology and toxicity of emerging synthetic cannabinoid receptors agonists (Spice/K2) and the molecular mechanisms underlying the potential therapeutic actions of cannabis and its components.
Education/Academic qualification
Pharmacology, PhD, University of Washington (UW)
Award Date: 18 Dec 1992
Pharmacology, Genetics, BSc (Hons), University of Sydney
Award Date: 25 May 1988
Fingerprint
Dive into the research topics where Mark Connor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Development of next-generation targeted therapies for epilepsy and pain based on cannabinoid derivatives
Bladen, C. & Connor, M.
3/07/17 → …
Project: Research
-
Advanced protein quantification capability
Walker, A. K., Lee, A., Connor, M., Atkin, J., Lim, E., Baker, M. S., Rizos, H., Phillips, J. K., Yang, S. & Blair, I.
1/01/17 → …
Project: Research
-
The pharmacology and toxicity of synthetic cannabinoids
Connor, M., Kassiou, M. & McGregor, I.
1/01/16 → …
Project: Research
-
Mechanisms underlying the repellent effects of predator odours in rodents
Connor, M., McGregor, I., Crowther, M. & Banister, S.
1/01/16 → …
Project: Research
Research Outputs
-
Do gabapentin or pregabalin directly modulate the µ receptor?
Manandhar, P., Murnion, B. P., Grimsey, N. L., Connor, M. & Santiago, M., 12 Apr 2021, In: PeerJ. 9, p. 1-16 16 p., e11175.Research output: Contribution to journal › Article › peer-review
Open AccessFile14 Downloads (Pure) -
Lifetime-engineered ruby nanoparticles (Tau-Rubies) for multiplexed imaging of μ-opioid receptors
Yang, X., Maleki, A., Lipey, N. A., Zheng, X., Santiago, M., Connor, M., Sreenivasan, V. K. A., Dawes, J. M., Lu, Y. & Zvyagin, A. V., 26 Mar 2021, In: ACS Sensors. 6, 3, p. 1375-1383 9 p.Research output: Contribution to journal › Article › peer-review
-
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro
Bladen, C., Mirlohi, S., Santiago, M., Longworth, M., Kassiou, M., Banister, S. & Connor, M., 1 Apr 2021, In: Neuropharmacology. 187, p. 1-11 11 p., 108478.Research output: Contribution to journal › Article › peer-review
-
Modulation of recombinant human T-type calcium channels by Δ9-tetrahydrocannabinolic acid in vitro
Mirlohi, S., Bladen, C., Santiago, M. & Connor, M., 21 Jan 2021, In: Cannabis and Cannabinoid Research. 12 p.Research output: Contribution to journal › Article › peer-review
-
The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist.
Moir, M., Lane, S., Montgomery, A. P., Hibbs, D., Connor, M. & Kassiou, M., 15 Jan 2021, In: European Journal of Medicinal Chemistry. 210, p. 1-28 28 p., 113087.Research output: Contribution to journal › Article › peer-review